Clinical trial
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00003220 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003220 |
|---|---|
| Title | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Study of Bryostatin 1 in Patients With Metastatic Colo-Rectal Adenocarcinoma |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1 |
| Start date | Feb 1, 1998 |
| Primary completion | Nov 1, 2000 |
| Completion | Jun 1, 2001 |
| First posted | Aug 13, 2004 |
| Last update posted | Apr 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: